| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 06, 2024 | Dec 10, 2024 | Palekar Rohan CEO | Buy | 89Bio, Inc. | ETNB | $7.89 | $39,450 | +1.05% |
| Nov 22, 2024 | Nov 25, 2024 | Palekar Rohan CEO | Buy | 89Bio, Inc. | ETNB | $8.35 | $83,500 | +2.10% |
| Apr 01, 2024 | Apr 03, 2024 | Palekar Rohan CEO | Sell | 89Bio, Inc. | ETNB | $10.91 | $575,153 | -10.30% |
| Feb 26, 2024 | Feb 28, 2024 | Palekar Rohan CEO | Sell | 89Bio, Inc. | ETNB | $10.76 | $48,173 | -0.91% |
| Dec 29, 2023 | Jan 03, 2024 | Palekar Rohan CEO | Sell | 89Bio, Inc. | ETNB | $11.2 | $560,000 | -14.24% |
| Jun 05, 2023 | Jun 07, 2023 | Palekar Rohan CEO | Sell | 89Bio, Inc. | ETNB | $20 | $300,000 | -4.97% |
| Mar 23, 2023 | Mar 27, 2023 | Palekar Rohan CEO | Sell | 89Bio, Inc. | ETNB | $16 | $240,000 | -5.28% |
| Jan 27, 2022 | Jan 31, 2022 | Palekar Rohan CEO | Buy | 89Bio, Inc. | ETNB | $7.05 | $52,850 | +14.06% |
| Jul 07, 2021 | Jul 08, 2021 | Palekar Rohan CEO | Buy | 89Bio, Inc. | ETNB | $16.84 | $117,850 | +15.91% |
| Nov 28, 2014 | Nov 29, 2014 | Palekar Rohan SVP Chief Commercial Officer | Sell | Avanir Pharmaceuticals, Inc. | AVNR | $15 | $225,000 | -4.72% |
| Sep 15, 2014 | Sep 18, 2014 | Palekar Rohan SVP Chief Commercial Officer | Sell | Avanir Pharmaceuticals, Inc. | AVNR | $11.5 | $287,500 | -8.57% |
| Dec 17, 2013 | Dec 19, 2013 | Palekar Rohan SVP Chief Commercial Officer | Buy | Avanir Pharmaceuticals, Inc. | AVNR | $2.8 | $28,000 | +6.54% |
| Nov 04, 2013 | Nov 06, 2013 | Palekar Rohan SVP Chief Commercial Officer | Buy | Avanir Pharmaceuticals, Inc. | AVNR | $4.19 | $41,895 | +6.99% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.